Go to deals
Healthcare

Lifco AB has acquired a majority stake in Rhein83 Srl

Lifco AB has acquired a majority stake in the Italian dental company Rhein83 Srl. Financial details have not been disclosed.

Lifco acquires and develops market-leading niche operations with the potential to deliver sustainable profit growth and strong cash flows. The group is listed on Nasdaq Stockholm and has three business areas: dental, demolition & tools and systems solutions. The company has a clear corporate philosophy which implies a long-term perspective, focus on profits and a highly decentralized organization. As of today, the investment group controls circa140 companies in 30 countries, generating revenues of over US$1 billion.

Established in 1983 and located in Bologna, Italy, Rhein83 has innovated the dental market with the introduction of elastic spherical attachments (previously were only metallic) for dental implants. The company's technology is highly recognized and appreciated worldwide.

Oaklins' team in Italy advised the buyer in this transaction.

Service
M&A buy-side
Parties
“Italy has many leading companies active in niche markets. Rhein83 is one of them. We are very excited for having complete this first acquisition in Italy and we hope this will be the first of many other acquisitions, both in the dental and industrial sectors, where we are discovering outstanding companies with great performance.”

Ingvar Ljungqvist

Head of Acquisitions, Lifco AB

Talk to the deal team

 Enrico  Arietti

Enrico Arietti

Partner

Turin, Italy
Oaklins Italy
 Marco  Croci

Marco Croci

Associate

Turin, Italy
Oaklins Italy

Related deals

Narva clinics has been acquired by Narva Åderbråckscenter AB
Healthcare

Narva clinics has been acquired by Narva Åderbråckscenter AB

The founder and some key employees of Åderbråcksspecialisterna Narva Kirurg Center AB and Narva Derma Center AB (Narva) have completed an MBO.

Learn more
NS PARTNERS CO., LTD. has been acquired by JMDC Inc.
Healthcare

NS PARTNERS CO., LTD. has been acquired by JMDC Inc.

Noritsu Koki Co., Ltd has sold NS PARTNERS CO., LTD. to JMDC Inc.

Learn more
Protalix BioTherapeutics, Inc. has completed a private stock placement
Healthcare

Protalix BioTherapeutics, Inc. has completed a private stock placement

Protalix BioTherapeutics, Inc. has raised funds to refinance the company for further development.

Learn more